Navigation Links
Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
Date:7/17/2012

ve European countries of the UK, France, Italy, Germany and Spain; and Japan.

Cancer is considered to be one of the most feared diseases, a cure for which has so far eluded researchers all over the world. However, new lines of therapeutics Vascular Endothelial Growth Factor (VEGF) inhibitors and Epidermal Growth Factor Receptor (EGFR) inhibitors are expected to make a significant impact on patient survival. However, progress in patient survival and other benefits are accompanied by premium prices, which has necessitated the creation of several agencies responsible for making decisions pertaining to pricing and reimbursement for cancer drugs in many countries of the world in order to contain costs related to cancer treatment. The report on "Pharmaceutical Pricing and Reimbursement in Oncology " delves into these recent changes in pricing and reimbursement mechanisms that are often targeted at expensive cancer drugs.

Scope

- Detailed study of the healthcare systems and roles of the key players in the respective pharmaceutical systems of the top seven countries of the world – the US, the UK, France, Germany, Italy, Spain and Japan.

- Analysis of the major pricing and reimbursement mechanisms in each country.

- Key trends that follow from the recent changes brought about in pricing and reimbursement mechanisms.

- Analysis of the possible major challenges brought about by the enactment of changes in the pricing and reimbursement scene in the countries covered in the report.

- Particular focus on pricing and reimbursement in oncology.

Reasons to buy

- Build an understanding of the oncology-related key pricing and reimbursement mechanisms in the top seven countries of the world.

- Optimize your investment through identification and understanding of the changes in oncology drugs' regulatory mechanisms and in the pricing and reimbursement scenario for the countries covered in the report.

<
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift from Traditional Mass-Media Platforms towards Personalization via Online and Social Media
2. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
3. Par Pharmaceutical Companies, Inc. Shareholder Alert: Bernstein Liebhard LLP Announces Investigation Of Acquisition By TPG
4. 81,200 Square Foot Lease Extension In San Diego Through 2018 Signed By Vertex Pharmaceuticals And BioMed Realty
5. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
6. Ampio Pharmaceuticals Announces Exercise of Over-Allotment Option
7. Par Formulations (Formerly Edict Pharmaceuticals) Receives First ANDA Approval
8. ResearchMoz.US: Direct to Consumer (DTC) Advertising in Pharmaceuticals - Shift From Traditional Mass-Media Platforms Towards Personalization via Online and Social Media- Market Research Report
9. Ampio Pharmaceuticals Announces Pricing of Public Offering of 4,615,400 Shares of Common Stock
10. Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
11. Ampio Pharmaceuticals Announces Proposed Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... , July 29, 2014 /PRNewswire-iReach/ -- The global ... of products, methods, applications, end users, and geographies. ... in the microbial identification market. This favorable growth ... (per test) and the time required for microbial ... technological advancements. Furthermore, genotypic methods have high applications ...
(Date:7/29/2014)... Amgen (NASDAQ: AMGN ) today announced financial ... include: , Total revenues increased 11 percent to ... by strong performance across the portfolio, particularly Enbrel ® ... (denosumab) and XGEVA ® (denosumab). , Adjusted ... revenues and a significant increase in the profitability of ...
(Date:7/29/2014)... 29, 2014  Express Scripts Holding Company (Nasdaq: ... attributable to Express Scripts stockholders of $515.2 million, or ... as detailed in Table 4, was $1.23 for the ... positioned to serve our clients with scale, alignment and innovative ... the health outcomes of our members," stated George Paz, chairman ...
Breaking Medicine Technology:Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 2Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 3Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 4Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 5Microbial Identification Market Growing at 5.9% CAGR to 2019: Global Forecast in New Research Report Available at ReportsnReports.com 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 2Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 4Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 5Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 7Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 8Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 9Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 10Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 11Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 12Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 13Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 14Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 15Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 16Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 17Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 18Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 19Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 20Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 21Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 22Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 23Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 24Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 25Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 2Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 3Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 4Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 5Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 6Express Scripts Announces 2nd Quarter Results; Narrows 2014 Guidance Range; Maintains Mid-Point 7
(Date:7/29/2014)... The Mesothelioma Applied Research Foundation (Meso Foundation) along ... advocacy efforts among its members for increased participation of ... the Deadliest Cancers. , As a result of ... members: , Rep. Matt Salmon (AZ-5) – June 18, 2014, ... Lofgren (CA-19) – June 19, 2014, Rep. Adam Schiff (CA-28) ...
(Date:7/29/2014)... 2014 Daily Gossip indicates that the ... other disturbing symptoms that hemorrhoids commonly causes. The new ... natural medicine expert. , The author of H ... elimination of symptoms such as itching, burning, pain and ... about the H Miracle by visiting the official website ...
(Date:7/29/2014)... chemical alteration in a single human gene linked to ... give doctors a simple blood test to reliably predict ... described online in The American Journal of Psychiatry ... the function of the brain,s response to stress hormones ... be an unremarkable reaction to the strain of everyday ...
(Date:7/29/2014)... PHILADELPHIA Use of electroacupuncture (EA) a ... is passed between pairs of acupuncture needles ... in as little as eight weeks for early ... to the use of aromatase inhibitors (AIs) to ... placebo-controlled trial examining the intervention led by researchers ...
(Date:7/29/2014)... 30, 2014)A diet rich in soy may help feminine ... online today in Menopause , the journal of ... similar to the diet of women in Asia, produces ... menopause, similar to Asian migrants to North America, leads ... diet, and switching to soy from a Western diet ...
Breaking Medicine News(10 mins):Health News:Mesothelioma Organization Works to Add Members to ‘Deadliest Cancer Caucus’ 2Health News:Mesothelioma Organization Works to Add Members to ‘Deadliest Cancer Caucus’ 3Health News:H Miracle Review Exposes Natural Method to Cure Hemorrhoids 2Health News:A blood test for suicide? 2Health News:A blood test for suicide? 3Health News:Acupuncture improves quality of life for breast cancer patients using aromatase inhibitors 2Health News:Acupuncture improves quality of life for breast cancer patients using aromatase inhibitors 3Health News:Soy may help women's hearts if they start early 2
... conjunction with its first quarter 2009 earnings release (expected to be ... CVD ) is pleased to invite you to listen ... over the Internet on Thursday, April 30, 2009 at 9:00 a.m. ... Webcast and Slide Presentation, When: April 30, ...
... (Nasdaq: CSCX ), a global leader in automated external defibrillator ... , cardiac stress test , Holter ... EMR and HIS systems, announced today that it ... 2009 after market close. The Company has scheduled a conference call with ...
... CORDOVA, Calif. , April 30 /PRNewswire-FirstCall/ ... leading supplier of innovative products that process and store adult ... the fiscal third quarter ended March 31, 2009, on Wednesday, ... , Management will host a conference call Wednesday, ...
... scientific collaboration has discovered that an electronic nose developed ... also be used to detect odour differences in normal ... study open up new possibilities for neurosurgeons in the ... of Hope Cancer Center, along with scientists from the ...
... of healthcare on-demand patient and staff education, healthcare televisions and ... North Carolina,s member-supported statewide television network, to bring UNC-KD, a ... a day, to children,s hospitals throughout North Carolina. , ... ...
... team up to ensure international students can travel safely; Tuition Fee protection ... ... 30, 2009 -- With a rise in interest from students and faculty ... Travel Insurance Services) Corp. has teamed up with Student Funding Group (StuFund) ...
Cached Medicine News:Health News:Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call 2Health News:Cardiac Science Schedules First Quarter Earnings Release and Announces Conference Call 3Health News:ThermoGenesis Corp. to Announce Third Quarter Fiscal 2009 Results on May 6, 2009 2Health News:NASA's electronic nose may provide neurosurgeons with a new weapon against brain cancer 2Health News:TeleHealth Services and UNC-TV Partner to Bring Kids Channel to North Carolina Children's Hospitals 2Health News:TeleHealth Services and UNC-TV Partner to Bring Kids Channel to North Carolina Children's Hospitals 3Health News:New G1G Student Medical Insurance and Student Fee Protection Now on StuFund Web Site 2Health News:New G1G Student Medical Insurance and Student Fee Protection Now on StuFund Web Site 3
Inquire...
... The most energy efficient refrigerator on ... even cooling throughout the unit. The contoured ... action. The steel outer walls are coated ... and the textured steel door is reversible. ...
... F340 is a basic laboratory system for ... results can be obtained when used with ... electrode. • Fast and easy one and ... for five buffers (pH 1.68, 4.00, 7.00, ...
... Multimode Detectors provide unmatched value and ... and automation needs. Capable of performing ... the same instrument, the DTX Series ... can be integrated seamlessly with Beckman ...
Medicine Products: